Statins and the risk of dementia (Q34511970)

2 August 2017

Statins and the risk of dementia (English)

1 reference

2 August 2017

0 references

4

1 reference

2 August 2017

H Jick

1

0 references

author name string

G L Zornberg

series ordinal

2

1 reference

2 August 2017

S S Jick

series ordinal

3

1 reference

2 August 2017

D A Drachman

series ordinal

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

2 August 2017

1 reference

2 August 2017

356

1 reference

2 August 2017

1627-1631

1 reference

2 August 2017

9242

1 reference

Incidence of clinically diagnosed subtypes of dementia in an elderly population. Cambridge Project for Later Life

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903155-X

7 January 2021

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903155-X

7 January 2021

New criteria for the diagnosis of vascular dementia: do we know enough yet?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903155-X

7 January 2021

Fronto-temporal dementia: nosology, neuropsychology, and neuropathology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903155-X

7 January 2021

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903155-X

7 January 2021

Inheritance of frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903155-X

7 January 2021

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903155-X

7 January 2021

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903155-X

7 January 2021

Brain infarction and the clinical expression of Alzheimer disease. The Nun Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903155-X

7 January 2021

The role of cholesterol in the biosynthesis of beta-amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903155-X

7 January 2021

Role of the low-density lipoprotein receptor-related protein in beta-amyloid metabolism and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903155-X

7 January 2021

Use of the UK General Practice Research Database for pharmacoepidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903155-X

7 January 2021

Postmenopausal Estrogen Replacement Therapy and the Risk of Alzheimer Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903155-X

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903155-X

7 January 2021

Regular Aspirin Intake and Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903155-X

7 January 2021

Principles of epidemiological research on adverse and beneficial drug effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903155-X

7 January 2021

Drug treatment of lipid disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903155-X

7 January 2021

Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903155-X

7 January 2021

Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903155-X

7 January 2021

HMG-CoA reductase inhibitors (statins): a promising approach to stroke prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903155-X

7 January 2021

Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903155-X

7 January 2021

Low-density lipoprotein-independent effects of statins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903155-X

7 January 2021

Association between Alzheimer's disease and the NOS3 gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903155-X

7 January 2021

Aberrant expression of nitric oxide synthase III in Alzheimer's disease: relevance to cerebral vasculopathy and neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903155-X

7 January 2021

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903155-X

7 January 2021

10.1016/S0140-6736(00)03155-X

Identifiers

DOI

1 reference

2 August 2017

1 reference